Autoimmune Blistering Diseases Study
Recruiting
Observational Study
Pemphigus Vulgaris
Pemphigus Foliaceus
Bullous Pemphigoid
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- University of Pennsylvania · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trials in pemphigus and BP will require the availability of validated disease severity measures that can be used to define primary outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Gender/Age: Males or females above 18 years old
* Diagnosis: pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid
* Subjects able to give informed consent
Exclusion Criteria:
* Patients who are under age 18 years.
* Patients without pemphigus or pemphigoid diseases
* …
Contacts